RICHMOND, Va. and SLOUGH, England, Nov. 30, 2017 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that the U.S. Food and Drug Administration (FDA) has approved SUBLOCADETM (buprenorphine extended- release) injection for subcutaneous use (CIII), the first and only once-monthly...
Press Release
|